Founder, CEO, Board Director. Oliver was co-founder of Biognosys in 2008 and is leading the company as CEO, starting as a spin-off from ETH Zurich to a market-leading inventor and provider of proteomics technology that Biognosys is today. A psychologist and biochemist by training, Oliver joined the group of proteomics pioneer Ruedi Aebersold at the ETH in 2005, where he worked on the development of technologies for targeted and structural proteomics and contributed to the seminal papers and patents in the Aebersold group that laid the foundation of the next-generation proteomics. Oliver is also a member of the Board of Directors of Biognosys.